Kolexia
Bally Stephane Néphrologie
Bally Stephane
Néphrologie
Hôpital Chambéry
Chambéry, France
36 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Vascularite Syndrome hémolytique et urémique Atteinte rénale aigüe Microangiopathies thrombotiques Syndrome hémolytique et urémique atypique Vascularites associées aux anticorps anti-cytoplasme des neutrophiles Hypertension artérielle Hémolyse Vascularite systémique

Collaborateurs

Voir plus
Fourcade Jacques
Fourcade Jacques
Hôpital Chambéry, Chambéry, France
Croze Laure-Emmanuelle
Croze Laure-Emmanuelle
Hôpital Chambéry, Chambéry, France
Morel Bertrand
Morel Bertrand
Hôpital Chambéry, Chambéry, France
Maynard Claire
Maynard Claire
Hôpital Chambéry, Chambéry, France

Industries

Voir plus
Sanofi
2 collaboration(s)
Dernière en 2023
EXAFIELD
1 collaboration(s)
Dernière en 2022
Vifor
1 collaboration(s)
Dernière en 2023
STETHOS
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study.
PloS one   30 décembre 2022
HAMA: A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Essai Clinique (Centre Hospitalier de Pau)   30 août 2022
Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
Journal of the American Society of Nephrology : JASN   24 janvier 2022
Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study.
Blood   07 décembre 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.
The Lancet. Rheumatology   05 novembre 2021
Impact of publication bias in the pharmacogenetics of antiepileptic drugs’ adverse reactions: A systematic umbrella review and meta-epidemiological study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
Amoxicillin induced crystal nephropathy : Monitoring of residual plasma levels.
Nephrologie & therapeutique   24 mai 2021
Carfilzomib-induced haemolytic and uremic syndrome: Favorable outcome with eculizumab.
Nephrologie & therapeutique   19 juin 2020
Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review.
Rheumatology (Oxford, England)   26 mars 2020
STOPECU: Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Essai Clinique (CHU Nantes)   05 décembre 2019